* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download CONGENITAL, PERINATAL, AND NEONATAL INFECTIONS
Herpes simplex virus wikipedia , lookup
Brucellosis wikipedia , lookup
Meningococcal disease wikipedia , lookup
Trichinosis wikipedia , lookup
Orthohantavirus wikipedia , lookup
Chagas disease wikipedia , lookup
Oesophagostomum wikipedia , lookup
Dirofilaria immitis wikipedia , lookup
Onchocerciasis wikipedia , lookup
Middle East respiratory syndrome wikipedia , lookup
West Nile fever wikipedia , lookup
Sexually transmitted infection wikipedia , lookup
Antiviral drug wikipedia , lookup
Marburg virus disease wikipedia , lookup
Leptospirosis wikipedia , lookup
African trypanosomiasis wikipedia , lookup
Hospital-acquired infection wikipedia , lookup
Schistosomiasis wikipedia , lookup
Coccidioidomycosis wikipedia , lookup
Human cytomegalovirus wikipedia , lookup
Hepatitis C wikipedia , lookup
Lymphocytic choriomeningitis wikipedia , lookup
Hepatitis B wikipedia , lookup
RUBELLA & PREGNANCY DR. S .Asadi Infectious diseases specialist Shahid Beheshti university of medical sciences 1 Rubella History 1881 Rubella accepted as a distinct disease 1941 Associated with congenital disease (Gregg) 1961 Rubella virus first isolated 1967 Serological tests available 1969 Rubella vaccines available 2 Characteristics of Rubella • RNA enveloped virus, member of the togavirus family • Spread by respiratory droplets. • In the prevaccination era, 80% of women were already infected by childbearing age. 3 Clinical Features • maculopapular rash • lymphadenopathy • fever • arthropathy (up to 60% of cases) 4 Congenital, Perinatal, and Neonatal Viral Infections Intrauterine Viral Infections Rubella Cytomegalovirus (CMV) Parvovirus B19 Varicella-Zoster (VZV) Enteroviruses HIV HTLV-1 Hepatitis C Hepatitis B Lassa Fever Japanese Encephalitis Perinatal and Neonatal Infections Human Herpes Simplex VZV Enteroviruses HIV Hepatitis B Hepatitis C HTLV-1 5 Risks of rubella infection during pregnancy Preconception minimal risk 0-12 weeks 100% risk of fetus being congenitally infected resulting in major congenital abnormalities. Spontaneous abortion occurs in 20% of cases. 13-16 weeks deafness and retinopathy 15% after 16 weeks normal development, slight risk of deafness and retinopathy 6 Congenital Rubella Syndrome (CRS) 7 Congenital Rubella Syndrome Classical triad consists of cataracts, heart defects, and sensorineural deafness. Many other abnormalities had been described and these are divided into transient, permanent and developmental. Transient low birth weight, hepatosplenomegaly, thrombocytopenic purpura bone lesions, meningoencephalitis, hepatitis, haemolytic anemia pneumonitis, lymphadenopathy Permanent Sensorineural deafness, Heart Defects (peripheral pulmonary stenosis, pulmonary valvular stenosis, patent ductus arteriosus, ventricular septal defect) Eye Defects (retinopathy, cataract, microopthalmia, glaucoma, severe myopia) Other Defects (microcephaly, diabetes mellitis, thyroid disorders, dermatoglyptic abnormalities Developmental Sensorineural deafness, Mental retardation, Diabetes Mellitus, thyroid disorder 8 CRS case definitions (1) Suspected CRS: A child <1 year with • maternal history of rubella in pregnancy and/or • heart disease, or deafness, or eye signs: white pupil (cataract); diminished vision; pendular eye movement (nystagmus); squint; smaller eye ball (micropthalmos);larger eye ball (congenital glaucoma) 9 CRS case definitions (2) Clinically confirmed CRS: A child <1 year with two complications in group (a) or one from (a) and one from (b) (a) cataract(s), congenital glaucoma, congenital heart disease, loss of hearing, pigmentary retinopathy (b) purpura, splenomegaly, microcephaly, mental retardation, meningoencephalitis, radiolucent bone disease, jaundice with onset within 24 hours after birth. 10 CRS case definitions (3) Laboratory-confirmed CRS: An infant with a positive blood test for rubella-specific IgM and clinicallyconfirmed CRS. Congenital rubella infection (CRI): An infant with a positive blood test for rubella-specific IgM who does not have clinically-confirmed CRS. 11 Rates of CRS per 1000 live births in developing countries prior to vaccination • Country year CSR rate • • • • • • • • Israel Jamaica Iran Oman Panama Singapore Sri lanka Trinidad 1972 1972-81 1999 1986 1986 1969 1994-95 1982-83 1.7 0.4 1 0.7 2.2 1.5 0.9 0.6 12 Rubella susceptibility in women of childbearing age studies in developing countries prior to use of vaccine 25% or higher 10-24% Cutts et al. Bull WHO 1997;75:55-68 <10% 13 Rash of Rubella 14 15 16 Outcome • 1/3 rd will lead normal independent lives • 1/3 rd will live with parents • 1/3rd will be institutionalised The only effective way to prevent CRS is to terminate the pregnancy 17 Typical Serological Events following acute rubella infection Note that in reinfection, IgM is usually absent or only present transiently at a low level 18 Laboratory Diagnosis Diagnosis of acute infection • Rising titres of antibody (mainly IgG) - HAI, EIA • Presence of rubella-specific IgM - EIA Immune Status Screen • HAI is too insensitive for immune status screening • SRH, EIA and latex agglutination are routinely used • 15 IU/ml is regarded as the cut-off for immunity 19 Prevention (1) Antenatal screening • All pregnant women attending antenatal clinics are tested for immune status against rubella. • Non-immune women are offered rubella vaccination in the immediate post partum period. 20 Prevention (2) • Since 1968, a highly effective live attenuated vaccine has been available with 95% efficacy • Universal vaccination is now offered to all infants as part of the MMR regimen in the USA, UK and a number of other countries. • Some countries such as the Czech Republic continue to selectively vaccinate schoolgirls before they reach childbearing age. • Both universal and selective vaccination policies will work provided that the coverage is high enough. 21